Description
HALOBETASOL PROPIONATE is a topical steroid medication used to treat skin conditions such as eczema, psoriasis, and dermatitis. It works by reducing inflammation and itching in the affected area.
Direction of Use:
HALOBETASOL PROPIONATE is for external use only.
Apply a thin layer of the medication to the affected area and gently massage it in.
Use it as directed by your healthcare provider. Do not use more or less of it or use it more often than prescribed.
Contraindication:
Do not use HALOBETASOL PROPIONATE if you have a known allergy to any of its ingredients.
Consult your healthcare provider if you have any other medical conditions or are taking any other medications.
Doses and Administration:
The usual adult dose is a thin layer applied to the affected area twice daily.
The usual pediatric dose is a thin layer applied to the affected area once daily.
The duration of treatment should not exceed 2 weeks for adults and 1 week for children.
Side Effects:
The most common side effects of HALOBETASOL PROPIONATE include skin irritation, itching, burning, and redness.
If these side effects become severe or do not go away, contact your healthcare provider.
Other rare but serious side effects may include changes in skin color, stretch marks, and thinning of the skin.
Interactions:
HALOBETASOL PROPIONATE may interact with other topical medications, so inform your healthcare provider of all medications you are taking.
It may also interact with certain medical conditions, so inform your healthcare provider of any medical conditions you have.
Warnings and Precautions:
Avoid using HALOBETASOL PROPIONATE on broken, infected, or irritated skin.
Do not cover the treated area with a bandage or other dressing unless directed by your healthcare provider.
Avoid using HALOBETASOL PROPIONATE on the face, groin, or underarms unless directed by your healthcare provider.
Do not use HALOBETASOL PROPIONATE for longer than prescribed, as it can cause thinning of the skin and stretch marks.







Reviews
There are no reviews yet.